



In tro duc tion: He mo lysis is sti ll the mo st com mon rea son for re jec ti ng sam ples, whi le reob tai ni ng a new sam ple is an im por ta nt prob lem. The aim 
of this stu dy was to in ves ti ga te the eff ec ts of he mo lysis in diff e re nt he mo lysis le ve ls for mos tly used bioc he mi cal pa ra me te rs to pre ve nt un ne ces sa ry 
re jec tio ns.
Ma te ria ls and met ho ds: Sixteen heal thy vo lun tee rs we re en rol led in the stu dy. Four he mo lysis le ve ls we re con sti tu ted ac cor di ng to he mog lo bin 
con cen tra tio ns and they we re di vi ded in to fi  ve grou ps: Group I: 0-0.10 g/L, Group II: 0.10-0.50 g/L, Group III: 0.51-1.00 g/L, Group IV: 1.01-2.50 g/L, 
Group V: 2.51-4.50 g/L. Lysis was ac hie ved by mec ha ni cal trau ma.
Re sul ts: Hemo lysis in ter fe ren ce aff ec ted lac ta te de hydro ge na se (LD) and as par ta te ami not ran sfe ra se (AST) al mo st at un de tec tab le he mo lysis by 
vi sual in spec tion (plas ma he mog lo bin < 0.5 g/L). Cli ni cal ly mea nin gful va ria tio ns of po tas sium and to tal bi li ru bin were ob ser ved in mo de ra te ly he-
mo lyzed sam ples (he mog lo bin > 1 g/L). Ala ni ne ami not ran sfe ra se (ALT), cho les te rol, gam ma glu ta myltran sfe ra se (GGT), and inor ga nic phos pha te 
(P) con cen tra tio ns we re not in ter fe red up to se ve re ly he mo lyzed le ve ls (he mog lo bin: 2.5-4.5 g/L). Albu min, al ka li ne phos pha ta se (ALP), amyla se, 
chlo ri de, HDL-cho les te rol, crea ti ne ki na se (CK), glu co se, mag ne sium, to tal pro tein, trig lyce ri des, un sa tu ra ted iron bin di ng ca pa ci ty (UIBC) and uric 
acid diff e ren ces we re sta tis ti cal ly sig ni fi  ca nt, but re mai ned wit hin the CLIA li mi ts.
Con clu sion: To avoid prea na lyti cal vi sual in spec tion for he mo lysis de tec tion, im pro per sam ple re jec tion, and/or re run be cau se of he mo lysis, it is re-
com men ded in this stu dy that, rou ti ne deter mi na tion of plas ma or se rum free he mog lo bin con cen tra tio ns is important. For the ana lytes in ter fe red 
wi th he mo lysis, new sam ples ha ve to be reques ted.
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Original professional article
Intro duc tion
He mo lysis is the mo st com mon prea na lyti cal sour-
ce of er ror in cli ni cal la bo ra to ries and res pon sib le 
for near ly 60% of re jec ted sam ples (1,2). It may oc-
cur bo th in vi vo or in vit ro. The ra tio of in vi vo he-
mo lysis is on ly 3.2% of all the he mo lyzed spe ci me-
ns (3). In vit ro he mo lysis oc cu rs mo re of ten and it 
is cau sed by im pro per sam ple drawi ng, han dli ng 
or cen tri fu ga tion. Espe cial ly har dly col lec ted sam-
ples, or sto red and/or tran spor ted, ha ve in crea sed 
ris ks for he mo lysis.
Most of the he molyzed sam ples are bei ng re jec-
ted on pre-a na lysis sta ge ac cor di ng to the vi sual 
de tec tion of se rum in ter fe ren ces, even if the 
reques ted tes ts may not be in ter fe red wi th he mo-
lysis. Be si des, ac cor di ng to the re por ts, vi sual as-
ses sme nt of sam ple he mo lysis showed lit tle ag ree-
me nt wi th the ac tual con cen tra tion of he mog lo bin 
in ter fe re nt (4-7).
Con ver se ly, even if the he mo lysis is not vi sib le, the-
re is al so a dis char ge of the ce ll con sti tuen ts in to 
se rum or plas ma (8). So in vi sib le he mo lysis is an 
im por ta nt cau se of fal se re sul ts and has to be de-
tec ted be fo re the in ves ti ga tion pro ce du re. In crea-
sed num ber of bioc he mi cal tes ts, num ber of sam-
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ples and in crea sed au to ma tion ob li ga ted la bo ra-
to ry sta ff  to stu dy har der, gi ve re sul ts fas ter, so 
pre-a na lyti cal de ter mi na tion of he mo lyzed sam-
ple and de ter mi na tion of in ter fe red ana lytes be fo-
re ana lysis be ca me mo re im por ta nt.
Sin ce the knowled ge of pos sib le eff ec ts is im por-
ta nt for cor re ct in ter pre ta tion of the re sul ts, the 
aim of the pre se nt wo rk was to eva lua te the eff ec-
ts of he mo lysis in ter fe ren ces in diff e re nt le ve ls on 
rou ti ne com mon ly used bioc he mis try tes ts. Re sul-
ts of this stu dy may he lp to pre ve nt un ne ces sa ry 
re jec tio ns of sam ples.
Ma te ria ls and met ho ds
The ve nous blood sam ples, col lec ted from 16 heal-
thy vo lun tee rs, we re ta ken into 5 diff e re nt he pa ri-
ni zed tu bes (Va cuet te ®, Grei ner La bor tec hnik, Ger-
ma ny) to stu dy the eff e ct of in vit ro he mo lysis. 
Four sam ples we re drawn throu gh the need les of 
5 mL syrin ge (1.5 in ch, 21 gau ge) spee di ly for 2, 4, 
6 and 8 ti mes res pec ti ve ly to lyze the cel ls by mec-
ha ni cal trau ma to ob tain slig htly, mil dly, mo de ra-
te ly and se ve re ly he mo lyzed sam ples. They we re 
all cen tri fu ged at 1000 x g for 15 mi nu tes. This met-
hod of ce ll lysis was cho sen be cau se blood tran-
sfer ri ng in to a tu be by pus hi ng for ce ly down on 
the syrin ge plun ger is ana lo gous to the mec ha ni-
cal dis rup tion of erythro cytes that frequen tly oc-
curs du ri ng blood col lec tion. In this met hod the re 
is no stan dar di za tion way of the for ce ap plied whi-
le tran sfer ri ng the blood by syrin ge. Besi des eve ry 
pa tien ts’ fra gi li ty of red blood ce ll is diff e re nt, so 
free Hb con cen tra tio ns of all sam ples we re not cor-
re la ted wi th the for ce.
Af ter mea su ri ng free Hb con cen tra tio ns of the he-
mo lyzed sam ples, the sam ples we re grou ped ac-
cor di ng to their free Hb con cen tra tio ns. The exclu-
sion cri te ria of a he mo lyzed sam ple was the con-
cen tra tion of its free Hb con cen tra tion dis cor da nt 
wi th the deg ree of he mo lysis de ter mi ned for ea ch 
group, so the num ber of sam ples we re not equal 
at ea ch group.
Free Hb of the sam ples were mea su red spec trop-
ho to met ri cal ly (Shi mad zu Cor po ra tion; Kyo to, Ja-
pan) wi th Na2CO3 so lu tion (10 mg/100 mL) as a rea-
ge nt (9). Ab sor ban ces we re mea su red at 415, 450 
and 700 nm for all he mo lyzed and di lu ted plas ma.
To tal plas ma he mog lo bin was cal cu la ted ac cor di-
ng to the for mu la:
Hb = 154.7 × (A425) – 130.7 × 
(A450) – 123.9 × (A700) (9).
(Refe ren ce ran ges: 0-0.1 g/L for plas ma free Hb).
Spe ci me ns we re ca te go ri zed ac cor di ng to the Hb 
con cen tra tio ns in to 5 grou ps:
Group I (0-0.1 g/L), non he mo lyzed (N = 15);
Group II (0.10-0.50 g/L) slig htly he mo lyzed (N = 
12);
Group III (0.51-1.00 g/L) mi ldly he mo lyzed (N = 10);
Group IV (1.01-2.50 g/L) mo de ra tely he mo lyzed) (N 
= 15);
Group V (2.51-4.5 g/L) se ve rely he mo lyzed (N = 
12).
The re sul ts we re ana lyzed to de ter mi ne if slig ht, 
mi ld, mo de ra te or se ve re he mo lysis had a sig ni fi -
ca nt im pa ct on the ana lyte con cen tra tions.
All ana lytes we re mea su red wi th Olympus ana-
lyzer wi th ori gi nal rea gen ts (Olympus AU2700 sy-
stem rea ge nt, Olympus Diag nos ti ca GmbH, Lis-
mee han, O’Cal lag han’s Mil ls, Co. Cla re, Ire la nd).
Plas ma con cen tra tio ns of al bu min, al ka li ne phos-
pha ta se (ALP), ala ni ne ami not ran sfe ra se (ALT), α-A-
myla se, as par ta te ami not ran sfe ra se (AST), to tal bi-
li ru bin, cal cium, so dium, po tas sium, chlo ri de, to tal 
cho les te rol (TC), crea ti ne ki na se (CK), crea ti ni ne, 
gam ma glu ta myltran sfe ra se (GGT), glu co se, high 
den si ty li pop ro tein cho les te rol (HDL-C), iron (Fe), 
lac ta te de hydro ge na se (LD), mag ne sium, inor ga-
nic phos pha te, to tal pro tein, trig lyce ri de (TG), un-
sa turated iron bin di ng ca pa ci ty (UIBC), urea, uric 
acid we re ana lyzed in all grou ps.
The eff ec ts of the he mo lysis we re eva lua ted ac cor-
di ng to the to tal al lowab le er ror re com men da tio-
ns of Cli ni cal La bo ra to ry Im pro ve me nt Amen-
dmen ts (CLIA’88) (10) (Table 1). CLIA’ 88 re gu la tio ns 
ha ve es tab lis hed fi xed li mi ts for as ses si ng met hod 
and la bo ra to ry per for man ce for spe ci fi c re gu la ted 
ana lytes. In prac ti ce, the to tal al lowab le er ror for a 
gi ven ana lyti cal met hod mu st be le ss than the res-
Biochemia Medica 2011;21(1):79–85
  81
Ko seog lu M. et al. He mo lysis in ter fe ren ce
pec ti ve CLIA fi xed li mi ts for the ana lyte in ques-
tion.
Sta tis ti cal ana lysis
To com pare the con cen tra tio ns of the he mo lyzed 
sam ples wi th non he mo lyzed sam ples, bias per-
cen ta ge was cal culated by the for mu la:
[(CX – C1)/ C1)] x 100.
C1: con cen tra tion of non he mo lyzed sam ple,
CX: con cen tra tion of he mo lyzed sam ple.
All ana lyses we re per for med usi ng Sta tis ti cal Pac-
ka ge for So cial Scien ces sta tis ti cal pac ka ge (SPSS, 
ver sion 15.0 for Win dows XP). Wil coxon sig ne d-ra-
nk te st ana lysis was used; P va lues < 0.05 we re con-
si de red sta tis ti cal ly sig ni fi  ca nt.
Re sul ts
As a re su lt of the mec ha ni cal trau ma, the me dian 
free Hb con cen tra tio ns for grou ps I, II, III, IV and V 
we re mea su red as 0.02, 0.27, 0.75, 1.27 and 3.34 
g/L, res pec ti ve ly. At free he mog lo bin con cen tra-
tion 0.5 g/L, he mo lysis was vi sib le by the red co lor 
of the plas ma.The re sul ts of the in ves ti ga tio ns we-
re all pre sen ted in Tab le 1 and shown in Fi gu re 1. 
Lac ta te de hydro ge na se ap pea red to be mo st sen-
TAB LE 1 Met ho ds, me dian va lues of the ana lytes and free he mog lo bin con cen tra tio ns for ea ch group, % bias of ana lyte con cen tra-
tio ns in com pa ri son to the non he mo lyzed group, and ± ac cep tab le li mi ts of CLIA’ 88, ± de si rab le bias. Re sul ts wi th hig her than CLIA 
li mi ts and sta tis ti cal ly sig ni fi  ca nt diff e ren ces are mar ked in bo ld. 
Ana lyte Met hod No lysis
Free plas ma he mog lo bin, g/L
De si rab le bias, ± CLIA, ±
0.27 0.75 1.27 3.34
Al bu min
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To com pa re the va lues, bo th CLIA’88 al lowab le li mi ts and Ana lyti cal Qua li ty Spe ci fi  ca tio ns for de si rab le bias (14,18) we re gi ven.
* ac cor di ng to the stu die s (2,8).
§ To com pa re the va lues of cal cium wi th ac cep tab le li mi ts, % re sul ts we re con ver ted to mmol/L: 0.6% (0.05 mmol/L), 1.1% (0.025 mmol/L).
§ To com pa re the re sul ts of po tas sium wi th ac cep tab le li mi ts, % re sul ts we re con ver ted to mmol/L: 3.5% (0.14 mmol/L), 6.5% (0.26 mmol/L), 10.7% 
(0.44 mmol/L), 35.8 % (1.47 mmol/L).
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si ti ve to he mo lysis; the in crea se of ~ 1000 U of lac-
ta te de hydro ge na se per li ter re sul ted in a 4.5-fo ld 
hig her en zyme ac ti vi ty at 4.5 g of he mog lo bin per 
li ter of plas ma than at 0.27 g/L. A con si de rab le in-
crea se of 30 U/L in as par ta te ami not ran sfe ra se ac-
ti vi ty was a 2.5 fo ld in crea se in this en zyme’s ac ti-
vi ty in se ve re ly he mo lyzed plas ma (he mog lo bin < 
4.5 g/L).
In elec tro lytes, po tas sium va lues we re mo st aff ec-
ted, in di re ct pro por tion to the in crea sed plas ma 
free he mog lo bin con cen tra tion, the ave ra ge in-
crea se in po tas sium con cen tra tion bei ng 1.48 
mmol/L for he mog lo bin con cen tra tio ns up to 4.5 
g/L, or about 1.4 fo ld (Fi gu re 1).
Tab le 1 sum ma ri zes the in fl uen ce of he mo lysis on 
rou ti ne bioc he mis try tes ti ng. Diff e ren ces are gi ven 
as median va lues and per cen ta ge re la ti ve bias 
from the ba se li ne spe ci me ns (no lysis). As expec-
ted, LD, AST and po tas sium va lues showed sig ni fi -
ca nt in crea ses ap proxi ma te ly li near ly de pen de nt 
on the free Hb con cen tra tio ns in he mo lyzed plas-
ma. The re was a dec rea se (100%) in to tal bi li ru bin 
con cen tra tion (Figu re 1).
Values of inor ga nic phos pho rus we re sig ni fi  can tly 
in crea sed li near ly wi th the in crea sed free he mog-
lo bin con cen tra tio ns com paring wi th the ba se li ne 
spe ci me ns. Cli ni cal ly mea nin gful (ap proxi ma te ly 
1.2 fo ld) in crea ses in en zyme ac ti vi ties we re ob ser-
ved for GGT and ALT at 4.5 g of he mog lo bin per li-
ter of plas ma.
Of the ana lytes eva lua ted, the bias va lues re cor-
ded for albu min, al ka li ne phos pha ta se, amyla se, 
cal cium, chlo ri de, HDL-cho les te rol, crea ti ne ki na se, 
crea ti ni ne, glu co se, iron, mag ne sium, so dium, to-
tal pro tein, trig lyce ri des, un sa tu ra ted iron bin di ng 
ca pa ci ty, urea and uric acid we re lower than the 
CLIA al lowab le li mi ts even in spe ci me ns con tai ni-
ng up to 4.5 g/L of plas ma he mog lo bin al thou gh 
for so me ana lytes va ria tio ns we re sta tis ti cal ly sig-
ni fi  ca nt (P < 0.05) (Tab le 1).
Al thou gh the re was no gi ven ac cep tab le li mit for 
GGT in CLIA’ 88 con si de ra tio ns, we as su med the li-
mit as 20% li ke mo st of the ot her en zymes. For the 
un sa tu ra ted iron bin di ng ca pa ci ty the eva lua tion 
was do ne ac cor di ng to so me stu dies whi ch was 
de ter mi ned as ±10% (11,12).
Dis cus sion
Ana lytic he mo lysis inter fe ren ce oc cu rs when the 
con sti tuen ts of the plas ma are at lower con cen tra-
tio ns than the con sti tuen ts in erit hro cytes. The re-
lea se of erythro cytic con sti tuen ts can re su lt in in-
crea sed va lues for se rum. Di lu tion is anot her pos-
sib le eff e ct es pe cial ly for gro ss he mo lysis, and may 
re su lt in dec rea sed va lues. Whi le Hb ab sor ban ce 
pea ks oc cur at ~417, 540, and 575 nm and at 415 
nm (Soret wa ve) ab sor bs lig ht ve ry stron gly, the re-
fo re at these wa ve lengths, spec trop ho to met ric in-
ter fe ren ce oc cu rs due to an in crea se in the op ti cal 
ab sor ban ce or a chan ge in the bla nk va lue (8,11-
13).
Ce ll con ten ts at hig her con cen tra tio ns of po tas-
sium, phos pha te, AST and LD en ter the sur roun di-
ng plas ma when lysis of erythro cytes oc cu rs (8,14). 
As expec ted in the cur re nt stu dy AST, LD, and po-
tas sium values showed cli ni cal ly mea nin gful in-
crea ses li ke pre vious in ves ti ga tio ns (8,11-17,19). So 
we can say that even if mac ros co pi cal ly in vi sib le 
he mo lysis oc cu rs, AST and LD mea su re men ts may 
con tri bu te to hi gh va lues.
Free he mog lo bin wi th its pseu do-pe roxi da se ac ti-
vi ty in ter fe res in the bi li ru bin pro ce du re by in hi bi-

















FI GU RE 1. In ter fe rog ram for he mog lo bin and mea su red pa ra-
me te rs: LD, AST, po tas sium and to tal bi li ru bin.
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we fou nd sta tis ti cal ly low va lues for all grou ps as 
in li te ra tu re (11) and bioc he mi cal tes ti ng has to be 
do ne for this as say wi th a new sam ple at he mog lo-
bin con cen tra tio ns hig her than 1 g/L.
For cho les te rol, in crea se in con cen tra tion was sig-
ni fi  ca nt at 2.5 g/L of Hb le ve ls. Ac cor di ng to a stu-
dy, the inter fe ren ce may re su lt from Hb de com po-
si tion of hydro gen pe roxi de. This eff e ct can be 
com pen sa ted for by usi ng an ap prop ria te sam ple 
bla nk (15). For HDL-C, the in ter fe ren ce was not cli-
ni cal ly sig ni fi  ca nt up to 10 g/L of he mog lo bin con-
cen tra tion wi th the sa me as say met hod (20).
Al thou gh Hb is the ma jor sour ce of iron, he mo lysis 
has a ve ry lit tle eff e ct on the se rum iron as say whi-
ch may be cau sed by spec tral over lap and by a 
che mi cal reac tion be tween he mo lysa te and reac-
tion com po nen ts li ke ALP, GGT, amyla se and iron 
as says (11,12,21).
We fou nd a slig ht dec rea se in glu co se and uric 
acid. This eff e ct may be co me from a pre ma tu re 
de com po si tion of hydro gen pe roxi de by Hb (15). 
Di lu tio nal eff e ct cau sed by the lea ka ge of in tra cel-
lu lar com po nen ts in to the sur roun di ng fl uid es pe-
cial ly in se ve re he mo lysis may cau se lower va lues 
for glu co se, so dium and cal cium (14,19). In this stu-
dy no lysa te or any ot her so lu tion was ad ded in 
spe ci me ns whi ch may al so has a di lu tio nal eff e ct 
on the ana lysis.
Al thou gh CK is not a con sti tue nt of erythro cytes, 
in tra cel lu lar ade nyla te ki na se has been at tri bu ted 
to the in ter fe ren ce in the CK as say (14,19). Cor rec-
tion can be do ne by ad di ng in hi bi to rs su ch as ade-
no si ne mo nop hos pha te and dia de no si ne pen tap-
hos pha te, or by sub strac ti ng the ac ti vi ty mea su red 
in the ab sen ce of crea ti ne phos pha te (21).
Nowa days se rum he mo lysis index is a po pu lar so-
lu tion for in ter fe ren ce de tec tion prea na lyti cal ly. 
Manu fac tu re rs gi ve the li st of te st-spe ci fi c se rum 
indices for he mo lysis, li pe mia and bi li ru bin in ter fe-
ren ces. This can he lp la bo ra to ry sta ff  to be awa re 
of in ter fe ren ce, stu dy or re je ct the sam ple, and 
add com men ts to the re su lts. But the stan dar di za-
tion prob lem of the va rious ana lyti cal syste ms and 
diff e re nt de ci sion thres hol ds for va rious se rum in-
di ces requi res mo re eff o rt (22).
Con clu sion
We con clu de that he mo lysis aff ec ts plas ma con-
cen tra tion of a who le ran ge of bioc he mi cal pa ra-
me te rs, whe reas the mo st pro mi ne nt eff e ct of he-
mo lysis is ob ser ved for AST, LD, po tas sium and to-
tal bi li ru bin. For ot her ana lytes; albu min, ALP, 
amyla se, chlo ri de, CK, HDL-cho les te rol, glu co se, 
mag ne sium, to tal pro tein, trig lyce ri des, UIBC and 
uric acid, diff e ren ces we re sta tis ti cal ly sig ni fi  ca nt, 
but re mai ned wit hin the CLIA li mi ts. We the re fo re 
re com me nd rou ti ne free Hb le vel de ter mi na tion in 
se rum or plas ma, or any ot her au to ma ted de tec-
tion of the deg ree of he mo lysis. On ly for tho se 
ana lyses whi ch are aff ec ted by the es ti ma ted deg-
ree of he mo lysis, new sam ples ha ve to be reques-
ted. Al thou gh ti me con su mi ng, this pro ce du re is 
hig hly use ful, sin ce it may he lp to avoid un ne ces-
sa ry re run the sam ples and re du ce the cos ts.
Refe ren ces
 1. Bo ni ni P, Ple ba ni M, Ce riot ti F, Rub bo li F. Er ro rs in la bo ra to-
ry me di ci ne. Clin Chem 2002;48:691-8.
 2. Ple ba ni M, Car ra ro P. Mis ta kes in a stat la bo ra to ry: types 
and frequen cy. Clin Chem 1997;43:1348-51.
 3. Car ra ro P, Ser vi dio P, Ple ba ni M. Hae mo lyzed spe ci me-
ns: a rea son for re jec tion or cli ni cal chal len ge? Clin Chem 
2000;46:306-7.
 4. Hin ckley C. De fi  ni ng the be st qua li ty-con trol syste ms by de-
si gn and in spec tion. Clin Chem 1997;43:873-9.
 5. Gli ck M, Ryder K, Jac kson S. Grap hi cal com pa ri so ns of in ter-
fe ren ces in cli ni cal che mis try in stru men ta tion. Clin Chem 
1986;32:470-5.
 6. Ple ba ni M. La bo ra to ry er ro rs: How to im pro ve pre-a nd po-
st-a na lyti cal pha ses? Bioc hem Med 2007;17:5-9.
 7. Si mun dic AM, Ni ko lac N, Ivan ko vic V, Fe re ne c-Ru zic D, 
Mag dic B, Kva ter nik M, To pic E. Com pa ri son of vi sual 
vs.automated de tec tion of li pe mic, ic te ric and he mo lyzed 




Ko seog lu M. et al. He mo lysis in ter fe ren ce
 8. Tho mas L. Hae mo lysis as in fl uen ce and in ter fe ren ce fac tor. 
eJIF CC vol 13 no 4: Avai lab le at: http://www.ifcc.org/ejifcc/
vol13no4/130401002.htm. Aces sed: Sep tem ber 25, 2010.
 9. Fair ban ks VF, Klee GG. Bioc he mi cal as pec ts of he ma to lo-
gy. In: Bur tis CA, As hwood ER, eds. Tie tz Textbook of Cli ni-
cal Che mis try. 3rd ed. Phi la del phia: WB Saun de rs Com pa-
ny; 1999. p.1673-6.
10. Cli ni cal La bo ra to ry Im pro ve men ts Amen dmen ts of 1988. 
Fi nal Ru le. La bo ra to ry Requi re men ts. Fe de ral Re gis ter 
1992;57:7002-288.
11. Son ntag O. Hae mo lysis as an in ter fe ren ce fac tor in cli ni cal 
che mis try. J Clin Chem Clin Bioc hem 1986;24:127-39.
12. Jay DW, Pro va sek D. Cha rac te ri za tion and mat he ma ti cal 
cor rec tion of he mo lysis in ter fe ren ce in se lec ted Hi tac hi 717 
as says. Clin Chem 1993;39:1804-10.
13. Graf meyer D, Bon don M, Man chon M, Le vil lain P. The in-
fl uen ce of bi li ru bin, hae mo lysis and tur bi di ty on 20 ana-
lyti cal tes ts per for med on au to ma tic ana lyse rs. Re sul ts 
of an in ter la bo ra to ry stu dy. Eur J Clin Chem Clin Bioc hem 
1995;33:31-52.
14. Lip pi G, Sal vag no LG, Mon tag na na M, Broc co G, Gui di GC. 
In fl uen ce of he mo lysis on rou ti ne cli ni cal che mis try tes ti ng. 
Clin Chem Lab Med 2006;44:311-6.
15. Yu cel D, Dal va C. Eff e ct of in vit ro he mo lysis on 25 com mon 
bioc he mi cal tes ts. Clin Chem 1992;38:575-7.
16. Sco tt MG, Heu sel JW, Le Grys VA, Sig gaa rd AO. In: Bur tis CA, 
As hwood ER, eds. Tie tz Textbook of Cli ni cal Che mis try. 4th 
ed. Phi la del phia: WB Saun de rs Com pa ny; 2006.p.1058-60.
17. Ran da ll AG, Gar cia-We bb P, Beil by JB. In ter fe ren ce by hae-
mo lysis, ic te rus and li pae mia in as says on the Bec kman 
Synchron CX5 and met ho ds for cor rec tion. Ann Clin Bioc-
hem 1990;27:345-52.
18. Ri cos C, Al va rez V, Ca va F, Gar cia –La rio JV, Her nan dez A, 
Ji me nez CV, et al. Cur re nt da ta ba ses on bio lo gic va ria tion: 
pros, co ns and prog re ss. Scan J Clin Lab In ve st 1999;59:491-
500.
19. Fra nk JJ, Ber mes EW, Bic kel MJ, Wat ki ns BF. Eff e ct of in vit-
ro he mo lysis on che mi cal va lues for se rum. Clin Chem 
1978;24: 1966-70.
20. Nau ck M, März W, Wie la nd H. New im mu no se pa ra tio n-ba-
sed ho mo ge neous as say for HDL-cho les te rol com pa red wi-
th three ho mo ge neous and two he te ro ge neous met ho ds 
for HDL-cho les te rol. Clin Chem 1998;44:1443-51.
21. Sza sz G, Ger har dt W, Gru ber W, Ber nt E.Creatine ki na se in 
se ru m:2. In ter fe ren ce of ade nyla te ki na se wi th the as say. 
Clin Chem 1976;2:1806-11.
22. Si mun dic AM, To pic E, Ni ko lac N, Lip pi G. He mo lysis de tec-
tion and ma na ge me nt of he mo lysed spe ci me ns. Bioc he-
mia Me di ca 2010;20:154-9.
Učin ci he mo li ze na ru tin sko od re đi va nje bio ke mij skih pa ra me ta ra
Sažetak
Uvod: He mo li za je još uvi jek naj češ ći raz log od bi ja nja uzo ra ka, ia ko je po nov no do bi va nje uzor ka ve lik prob lem. Cilj ovog is tra ži va nja je is pi ta ti 
učin ke he mo li ze u nje nim raz nim stup nje vi ma za naj češ će od re đi va ne bio ke mij ske pa ra met re ka ko bi se spri je či la ne pot reb na od bi ja nja.
Me to de i is pi ta ni ci: U is pi ti va nje je uk lju če no šes nae st zdra vih dob ro vo lja ca. Pre ma kon cen tra ci ja ma he mog lo bi na od re đe na su če ti ri stup nja 
he mo li ze, a is pi ta ni ci su po di je lje ni u pet sku pi na: Sku pi na I: 0-0,10 g/L, Sku pi na II: 0,10-0,50 g/L, Sku pi na III: 0,51-1,00 g/L, Sku pi na IV: 1,01-2,50 
g/L, Sku pi na V: 2,51-4,50 g/L. Li za erit ro ci ta je pos tig nu ta me ha nič kom trau mom.
Re zul ta ti: In ter fe ren ci ja us li jed he mo li ze ut je ca la je na od re đi va nje ak tiv nos ti lak tat-de hid ro ge na ze (LD) i as par tat-ami not ran sfe ra ze (AST) kod 
go to vo nep re poz na te he mo li ze pri vi zual nom preg le du (kon cen tra ci ja he mog lo bi na u plaz mi < 0.5 g/L). Pri mi je će ne su kli nič ki zna čaj ne va ri ja-
ci je kon cen tra ci je ka li ja i ukup nog bi li ru bi na u um je re no he mo li zi ra nim uzor ci ma (he mog lo bin > 1 g/L). Kod od re đi va nja ak tiv nos ti ala nin-ami-
not ran sfe ra ze (ALT), ga ma-glu ta mil tran sfe ra ze (GGT) te kon cen tra ci je ko les te ro la i anor gan skog fos fa ta (P) ni su pri mi je će ne in ter fe ren ci je sve do 
stup nje va ja ke he mo li ze (he mog lo bin: 2,5-4,5 g/L). Raz li ke u ak tiv nos ti ma al kal ne fos fa ta ze (ALP), ami la ze, krea ti nin ki na ze (CK) te kon cen tra-
ci ja ma al bu mi na, klo ri da, HDL-ko les te ro la, glu ko ze, mag ne zi ja, ukup nog pro tei na, trig li ce ri da i mok rać ne ki se li ne te u ne za si će nom ka pa ci te tu 
ve zi va nja že lje za (UIBC) bi le su sta tis tič ki zna čaj ne, no unu tar doz vo lje nih gra ni ca pre ma CLIA kri te ri ji ma (en gl. Cli ni cal La bo ra to ry Im pro ve me nt 
Amen dmen ts, CLIA).
Zak lju čak: Ka ko bi se iz bjeg la pri jea na li tič ka me to da vi zual nog preg le da uzor ka za pre poz na va nje he mo li ze, neod go va ra ju će od bi ja nje uzo ra ka 
i/ili po nov no tes ti ra nje us li jed he mo li ze pre po ru ča se ru tin sko od re đi va nje kon cen tra ci je slo bod nog he mog lo bi na u plaz mi ili se ru mu, kao što 
po ka zu je ovo is tra ži va nje. Za od re đi va nje kon cen tra ci je ili ak tiv nos ti ana li ta ko ji čes to pod li je žu in ter fe ren ci ji zbog he mo li ze pot reb no je zat ra ži ti 
no vi uzo rak.
Ključ ne ri je či: he mo li za; pog r ješ ke u pri jea na li tič koj fa zi; in ter fe ren ci ja; ana li ti
